Company intelligence / Profile preview

Conscio Group

Munich, Bavaria, Germanyconsciogroup.com ↗

Ownership: Private
Development stage: Commercial

Overview

Conscio Group provides comprehensive contract R&D, analytical, clinical trial, and manufacturing services across the pharmaceutical lifecycle. They have completed over 600 bio-studies and offer expertise in method development, batch release testing, formulation development, and both small and large molecule analytics. Their network includes GMP/GLP/GCP/IEC-certified labs inspected by EMA & FDA.

Modalities: Small moleculeBiologicPeptidesProteins
Industry: Contract Research Organization

Beyond the preview

Go deeper on Conscio Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conscio Group.

Explore the full profile